Westlake Corporation
WLK
$80.63
+15.37%
Westlake Corporation is a forward-integrated global chemicals and materials company headquartered in Houston, producing essential products such as polyethylene, PVC, chlor-alkali, and building products across two primary segments: Performance and Essential Materials, and Housing and Infrastructure Products. As a North American leader in chlor-alkali and PVC following its 2016 acquisition of Axiall, Westlake differentiates itself through vertical integration, converting commodity chemicals into higher-margin finished goods. The current investor narrative centers on severe cyclical headwinds, as the company has swung to substantial losses amid weak demand and margin compression in its chemical end markets, while its housing and infrastructure segment provides some diversification. Recent geopolitical tensions, including the Iran conflict, have added uncertainty to global commodity prices, further pressuring near-term earnings and stock performance.…
WLK
Westlake Corporation
$80.63
Investment Opinion: Should I buy WLK Today?
Rating: Hold. Westlake is a cyclical chemicals company currently in a severe downturn, with negative earnings and cash flow. The analyst consensus is Buy with an average target of $96, implying 36% upside, but the fundamental deterioration and negative momentum suggest caution. The stock is not a buy for most investors until there are signs of a cyclical recovery.
Sign up to view all
WLK 12-Month Price Forecast
The AI assessment is bearish in the near term due to the severe fundamental deterioration and negative momentum. The company is losing money at the gross margin level, which is unsustainable. While the valuation is cheap on a PS basis, the lack of earnings visibility and negative cash flow suggest the stock could continue to decline. However, the low beta and dividend provide some downside support. The stance would upgrade to neutral if the company reports positive EBITDA and gross margins above 5%, and to bullish if revenue growth turns positive and margins recover to double digits.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Westlake Corporation's 12-month outlook, with a consensus price target around $96.00 and implied upside of +19.1% versus the current price.
Average Target
$96.00
0 analysts
Implied Upside
+19.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$85 - $114
Analyst target range
Westlake is covered by 15 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 2.33 (where 1 is Strong Buy and 5 is Sell). The average price target is $96.00, implying a substantial 36.2% upside from the current price of $70.50, indicating that analysts see significant value at current levels. The distribution includes 10 Buy ratings, 4 Hold ratings, and 1 Sell rating, reflecting a generally bullish sentiment despite the recent earnings deterioration.
Bulls vs Bears: WLK Investment Factors
Westlake is facing a severe cyclical downturn, with negative earnings, shrinking revenue, and negative cash flow, which explains the stock's 38.7% plunge over the past three months. However, the stock trades at a deep discount to its historical and industry valuation, and analysts see substantial upside with a consensus Buy and a 36% average target upside. The core tension is whether the current downturn is a temporary cyclical trough or the beginning of a prolonged structural decline, especially given the negative gross margin. If the cycle turns and earnings recover to analyst estimates, the stock could re-rate sharply; if not, the value trap could deepen. Currently, the bearish momentum and fundamental deterioration outweigh the valuation appeal, but the low beta and dividend provide some downside cushion.
Bullish
- Analyst consensus Buy with 36% upside: 15 analysts rate WLK a Buy (mean 2.33), with an average price target of $96.00, implying 36.2% upside from the current $70.50. The high target of $114 suggests even more upside if the cycle turns.
- Deep discount to industry PS ratio: Trailing PS is 0.85x versus the chemicals industry's typical 1.5-2.0x. This implies the market is pricing in severe margin pressure, but if earnings normalize, the stock could re-rate significantly.
- Forward PE suggests earnings recovery: Forward PE is 20.8x based on estimated EPS of $3.47, implying the market expects a strong rebound from the current -$0.16 TTM EPS. Analysts' EPS estimates range from $1.77 to $5.16, indicating a potential cyclical recovery.
- Housing segment provides diversification: The Housing and Infrastructure Products segment contributed $901 million in Q4 2025, about 36% of revenue. This segment helps offset some cyclicality in chemicals, though it is also currently weak.
Bearish
- Severe earnings deterioration: TTM EPS is -$0.16, and Q4 2025 EPS was -$4.22 with a net loss of $544 million. Gross margin turned negative at -17.3%, indicating the company is selling below cost, a dire sign for the chemicals cycle.
- Revenue declining double-digits: Q4 2025 revenue fell 10.9% YoY to $2.533 billion, and the trend has been steadily down from $2.846 billion in Q1 2025. This indicates weak demand across key end markets.
- Negative free cash flow and EBITDA: TTM free cash flow is -$530 million, and Q4 EBITDA was -$266 million. The company is burning cash, which could pressure dividends or force balance sheet actions if the downturn persists.
- Stock in steep downtrend: WLK is down 38.7% over the past 3 months and 11.1% over the past year, underperforming the S&P 500 by 29.3 percentage points. The stock trades near the low of its 52-week range, reflecting persistent selling pressure.
WLK Technical Analysis
Westlake's stock is in a pronounced downtrend, with the price at $70.50 as of July 31, 2026, down 11.1% over the past year and sitting near the bottom of its 52-week range (low $56.33, high $124.23). The stock is currently trading at approximately 19% of its 52-week range, indicating it is closer to the lows than the highs, which suggests bearish momentum and a potential value trap if fundamentals continue to deteriorate. The 1-year price change of -11.1% underperforms the S&P 500's +18.2% gain, highlighting significant relative weakness.
Beta
0.62
0.62x market volatility
Max Drawdown
-43.4%
Largest decline past year
52-Week Range
$56-$124
Price range past year
Annual Return
+5.7%
Cumulative gain past year
| Period | WLK Return | S&P 500 |
|---|---|---|
| 1m | +7.8% | +3.6% |
| 3m | -19.3% | +5.1% |
| 6m | -12.5% | +13.8% |
| 1y | +5.7% | +22.2% |
| ytd | +8.7% | +13.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WLK Fundamental Analysis
Revenue has been declining, with the most recent quarter (Q4 2025) showing revenue of $2.533 billion, down 10.9% year-over-year, and the trend over the past four quarters shows a steady decline from $2.846 billion in Q1 2025 to $2.533 billion in Q4 2025. The company's revenue segments show Performance and Essential Materials contributing $1.632 billion and Housing and Infrastructure Products $901 million, but both are under pressure from weak chemical demand and housing market softness. The negative revenue growth and sequential declines indicate a deteriorating demand environment, which is a major red flag for the investment case.
Quarterly Revenue
$2.5B
2025-12
Revenue YoY Growth
-10.9%
YoY Comparison
Gross Margin
-17.3%
Latest Quarter
Free Cash Flow
$-530000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WLK Overvalued?
Given that Westlake's trailing twelve-month net income is negative (EPS of -$0.16), the price-to-earnings ratio is not meaningful, so I selected the price-to-sales (PS) ratio as the primary valuation metric. The trailing PS ratio is 0.85x, while the forward PS ratio (based on estimated revenue) is approximately 0.75x, implying that the market expects a slight revenue recovery. The stock trades at a significant discount to the broader chemicals industry, which typically commands PS ratios of 1.5-2.0x, suggesting the market is pricing in continued margin pressure and earnings risk.
PE
-6.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~15x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-66.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are elevated. Westlake's TTM net income is negative, with EPS of -$0.16, and the company reported a net loss of $544 million in Q4 2025 alone. Gross margin turned negative at -17.3%, meaning the company is selling products below production cost, which is unsustainable. Free cash flow is -$530 million TTM, and EBITDA was -$266 million in Q4, indicating the company is burning cash. The debt-to-equity ratio of 0.73 is moderate, but with negative earnings, interest coverage is a concern. Revenue has declined for four consecutive quarters, from $2.846 billion in Q1 2025 to $2.533 billion in Q4 2025, reflecting weak demand across both segments. The company's reliance on commodity chemicals makes it highly sensitive to the economic cycle, and the current downturn is severe.